Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
123 hedge funds and large institutions have $251M invested in Flexion Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 28 closing their positions.
149% more call options, than puts
Call options by funds: $2.06M | Put options by funds: $828K
11% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 35
8% less funds holding
Funds holding: 133 → 123 (-10)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
63% less capital invested
Capital invested by funds: $670M → $251M (-$420M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.6M |
| 2 |
Neuberger Berman Group
New York
|
+$10.5M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.68M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.67M |
| 5 |
RA
Royce & Associates
New York
|
+$3.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$10.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.22M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.04M |
| 4 |
Bank of New York Mellon
New York
|
-$5.59M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$4.41M |
FLXN Hedge Fund Activity: Q1 2020 in Review
123 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2020, worth a combined $251M — down 63% from $670M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of FLXN and 21 opened new positions — a net loss of 7 holders — while 35 trimmed existing stakes and 39 added.
The largest buyer was Granahan Investment Management, opening a new position worth an estimated $10.6M. The largest seller was Miller Value Partners, cutting an estimated $10.4M.
- 123 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2020, down from 133 in Q4 2019.
- Funds reported $251M of Flexion Therapeutics, Inc. stock for Q1 2020, down 63% quarter-over-quarter.
- 21 funds opened new Flexion Therapeutics, Inc. positions in Q1 2020 and 28 closed out, a net change of -7 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2020 was Granahan Investment Management, an estimated $10.6M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2020 was Miller Value Partners, an estimated $10.4M sold.
Based on aggregated 13F filings for Q1 2020.